Selected Publications

Krithika Shanmugasundaram, Subir Goyal, Jeffery Switchenko, Oscar Calzada, Michael C Churnetski, Bhaskar Kolla, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie S Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, Narendranath Epperla, David A Bond, Talha Badar, Kristie A Blum, Mehdi Hamadani, Timothy S Fenske, Mary Malecek, Brad S Kahl, Peter Martin, Jin Guo, Christopher R Flowers, Jonathon B Cohen: Intensive Induction Regimens after Deferring Initial Therapy for Mantle Cell Lymphoma Are Not Associated with Improved Survival. Eur J Haematol May 2021.

Anthony R Mato 1 , Nirav N Shah 2 , Wojciech Jurczak 3 , Chan Y Cheah 4 , John M Pagel 5 , Jennifer A Woyach 6 , Bita Fakhri 7 , Toby A Eyre 8 , Nicole Lamanna 9 , Manish R Patel 10 , Alvaro Alencar 11 , Ewa Lech-Maranda 12 , William G Wierda 13 , Catherine C Coombs 14 , James N Gerson 15 , Paolo Ghia 16 , Steven Le Gouill 17 , David John Lewis 18 , Suchitra Sundaram 19 , Jonathon B Cohen 20 , Ian W Flinn 21 , Constantine S Tam 22 , Minal A Barve 23 , Bryone Kuss 24 , Justin Taylor 11 , Omar Abdel-Wahab 25 , Stephen J Schuster 15 , M Lia Palomba 25 , Katharine L Lewis 4 , Lindsey E Roeker 25 , Matthew S Davids 26 , Xuan Ni Tan 4 , Timothy S Fenske 27 , Johan Wallin 28 , Donald E Tsai 28 , Nora C Ku 28 , Edward Zhu 28 , Jessica Chen 28 , Ming Yin 28 , Binoj Nair 28 , Kevin Ebata 28 , Narasimha Marella 28 , Jennifer R Brown 26 , Michael Wang 29: Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Lancet March 2021.

Wright CM, LaRiviere MJ, Baron JA, Uche C, Xiao Y, Arscott WT, Anstadt EJ, Barsky AR, Miller D, LaRose MI, Landsburg DJ, Svoboda J, Nasta SD, Gerson JN, Barta SK, Chong EA, Schuster SJ, Paydar I, Maity A, Plastaras JP.: Bridging Radiation Therapy Before Commercial Chiemric Antigen Receptor T-Cell Therapy for Relapse or Refractory Aggressive B-cell Lymphoma. International Journal of Radiation Oncology, Biology, Physics 2021.

Gerson JN, Handorf E, Barta SK: Survival following First Relapse in Younger Patients with Mantle Cell Lymphoma. International Meeting on Malignant Lymphoma 2021 Notes: Lugano Switzerland.

Karmali R, Switchenko JM, Subir G, Shanmugasundaram K, Churnetski MC, Kolla B, Bachanova V, Gerson JN, Cohen J: Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era. American Journal of Hematology 2021.

Gerson JN, Barta SK: Mantle Cell Lymphoma and Hematopoietic Cell Transplantation in the era of Cellular Therapy. Journal of Clinical Haematology September 2020.

Joanna M Rhodes, Vincent A LoRe, Anthony R Mato, Elise A Chong, Jacqueline C Barrientos, James N Gerson, Stefan K Barta, Daniel J Landsburg, Sunita Dwivedy Nasta, Jakub Svoboda, Alison W Loren, Stephen J Schuster. : Ibrutinib-associated Arthralgias/Myalgias in Patients with Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes. Clin Lymphoma Myeloma Leuk 20(7): 438-444, July 2020.

Christopher M Wright, Michael J LaRiviere, Jonathan A Baron, Chibueze Uche, Ying Xiao, W Tristram Arscott, Emily J Anstadt, Andrew R Barsky, David Miller, Meredith I LaRose, Daniel J Landsburg, Jakub Svoboda, Sunita D Nasta, James N Gerson, Stefan K Barta, Elise A Chong, Stephen J Schuster, Ima Paydar, Amit Maity, John P Plastaras: Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma. Int J Radiat Oncol Biol Phys 108(1): 178-188, May 2020.

Mitchell E Hughes, Daniel J Landsburg, Daniel J Rubin, Stephen J Schuster, Jakub Svoboda, James N Gerson, Esin Namoglu, Sunita D Nasta. : Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use. Clin Lymphoma Myeloma Leuk 19(12): 791-798, Dec 2019.

James N Gerson, Stefan K Barta. : Mantle Cell Lymphoma: Which Patients Should We Transplant? Curr Hematol Malig Rep 14(4): 239-246, Aug 2019.